EP3564244
CRYSTALLINE FORMS OF (2R,5S,13AR)-8-HYDROXY-7,9-DIOXO-N-(2,4,6-TRIFLUOROBENZYL)-2,3,4,5,7,9,13,13A-OCTAHYDRO-2,5-METHANOPYRIDO [1',2':4,5]PYRAZINO [2,1-B][1,3]OXAZEPINE-10-CARBOXAMIDE
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
19.6.2015EP published:
13.9.2023EP application number:
19167626.1
EPO information:
European Patent Register
Max expiry date:
18.6.2035
Title in English:
CRYSTALLINE FORMS OF (2R,5S,13AR)-8-HYDROXY-7,9-DIOXO-N-(2,4,6-TRIFLUOROBENZYL)-2,3,4,5,7,9,13,13A-OCTAHYDRO-2,5-METHANOPYRIDO [1',2':4,5]PYRAZINO [2,1-B][1,3]OXAZEPINE-10-CARBOXAMIDELanguage of the patent:
English
Timeline
Today
19.6.2015EP application
13.9.2023EP Publication
Owner
Name:
Gilead Sciences, Inc.Address:
333 Lakeside Drive, Foster City, CA 94404, US
Inventor
Name:
CARRA, Ernest A.Address:
Foster City, CA 94404, US
Name:
CHEN, IreneAddress:
Foster City, CA 94404, US
Name:
KEATON, Katie AnnAddress:
Foster City, CA 94404, US
Name:
ZIA, VahidAddress:
Foster City, CA 94404, US
Priority
Number:
201462015238 PDate:
20.6.2014Country:
US
Number:
201462017183 PDate:
25.6.2014Country:
US
Classification
Categories:
C07D 498/14, A61K 31/537, A61P 31/18